drugset / Trial / NCT03890003
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes
NaSingle-groupOpen-labelDevice feasibility
Summary
The purpose of this early feasibility study is to assess the predictive low glucose suspend (PLGS) feature's safety, functionality and performance.
Timeline
- Start
- 2019-03-28
- Primary completion
- 2019-05-06
- Completion
- 2019-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |